Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Contribution of Gabaergic and Glutamatergic Mechanisms to Cognitive Dysfunction


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT00611572

Organisation Name: Yale University

Overal Status: Active, not recruiting

Start Date: January 2007

Last Update: July 27, 2020

Lead Sponsor: Yale University

Brief Summary: This study investigates the interactions between NMDA (N-Methyl-D-aspartic acid) antagonism and GABA (gamma-aminobutyric acid) system as it relates to cognitive function assessed by ERPs (event-related potentials) in healthy volunteers.

Conditions:
  • Cognitive Dysfunction


Total execution time in seconds: 0.21357417106628